Antimicrobial stewardship interventions in hospitalized adults with community-acquired pneumonia: a systematic review and meta-analysis
- PMID: 40202602
- DOI: 10.1007/s10096-025-05122-8
Antimicrobial stewardship interventions in hospitalized adults with community-acquired pneumonia: a systematic review and meta-analysis
Abstract
Purpose: This systematic review and meta-analysis evaluate the effectiveness of ASPs in managing community-acquired pneumonia (CAP), focusing on antibiotic optimization and resistance mitigation.
Methods: Comprehensive literature searches were conducted in PubMed, Scopus, and Web of Science using PICOS criteria. Studies involving adults with CAP exposed to ASPs were included. Data on clinical, economic, diagnostic, and treatment outcomes were extracted. Random-effects meta-analysis using R software pooled effect sizes. Outcomes reported in at least three studies were analyzed for robustness.
Results: ASPs did not significantly impact in-hospital mortality, length of stay, 30-day readmissions, sample collection rates, or intravenous antibiotic duration. However, notable improvements included shorter time to clinical stability and a 31% reduction in 30-day mortality. Legionella urinary antigen testing frequency increased nearly threefold, and the time from admission to antibiotic initiation was reduced. Enhanced adherence to timely antibiotic administration and recommended regimens was observed, though outcome variability persisted.
Conclusion: ASPs significantly improve CAP management by enhancing clinical stability and accelerating antibiotic initiation. Multifaceted strategies, including rapid diagnostics and clinician education, yield clinical benefits. However, outcome variability suggests a need for tailored interventions. Future research should isolate specific ASP components influencing prescriber behavior. Ongoing investment in education, diagnostics, and interdisciplinary collaboration is vital to optimize CAP treatment and combat antibiotic resistance.
Keywords: Attitudes; Community-acquired infections; Disease management; Health knowledge; Pneumonia; Practice.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical approval: Not applicable. Competing interests: The authors declare no competing interests.
References
-
- Hespanhol V, Barbara C (2020) Pneumonia mortality, comorbidities matter? Pulmonology 26(3):123–129 Epub 20191129. https://doi.org/10.1016/j.pulmoe.2019.10.003 - PubMed
-
- GBD 2017 Disease and Injury Incidence and Prevalence Collaborators (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159):1789–1858. https://doi.org/10.1016/S0140-6736(18)32279-7 . Epub 20181108.
-
- Kyaw BM, Tudor Car L, van Galen LS, van Agtmael MA, Costelloe CE, Ajuebor O et al (2019) Health professions digital education on antibiotic management: systematic review and Meta-Analysis by the digital health education collaboration. J Med Internet Res 21(9):e14984 Epub 20190912. https://doi.org/10.2196/14984 . PubMed PMID: 31516125; PubMed Central PMCID: PMC6746065 - PubMed - PMC
-
- Mohd Sazlly Lim S, Zainal Abidin A, Liew SM, Roberts JA, Sime FB (2019) The global prevalence of multidrug-resistance among acinetobacter baumannii causing hospital-acquired and ventilator-associated pneumonia and its associated mortality: A systematic review and meta-analysis. J Infect 79(6):593–600 Epub 20190930. https://doi.org/10.1016/j.jinf.2019.09.012 - PubMed
-
- Cilloniz C, Dominedo C, Torres A (2019) Multidrug resistant Gram-Negative bacteria in Community-Acquired pneumonia. Crit Care 23(1):79 Epub 20190309. https://doi.org/10.1186/s13054-019-2371-3 - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
